摘要
目的:观察安可来治疗哮喘患者的临床效果及其不良反应。方法:将轻、中度哮喘患者72例,随机平分为对照组和安可来治疗组,每组各36例。对照组患者用二羟丙茶碱0.5 g、抗生素、地塞米松10 mg溶于50 g/L葡萄糖250 ml中进行静脉滴注,1次/d,共8 d;安可来治疗组患者在对照组用药基础上口服安可来20 mg,2次/d。结果:对照组患者总有效率为77.8%,安可来治疗组患者为94.0%;两组患者疗效有显著性差异(P<0.01);两组患者治疗后FEV1,VC,FVC与治疗前比较具有显著性差异(P<0.01)。结论:安可来适用于治疗轻(或中度)哮喘患者。
Objective:To observe clinical effects and adverse reactions of Accolate in treatment of asthma. Methods:72 pa-tients with mild or moderate asthma were divided into control group and Accolate group, randomly, 36 cases in each group. The control group received Diprophylline 0. 5g, antibiotics and Dexamethasone 10mg in 250ml of 50g/L glucose through intravenous drip once/d for 8 days;while on the basis of those of control group, Accolate group orally took 20mg Accolate twice/d. Results:The total effective rates of Accolate group and control group were 94% and 77. 8%, respectively, and there was a significant difference between two groups (P<0. 01). Compared with those before the treatment, the FEV1, VC, FVC of the two groups after the treatment were signifi-cantly different (P<0. 01). Conclusions:Accolate is suitable for treating mild or moderate asthma.
出处
《中国民康医学》
2015年第19期9-10,23,共3页
Medical Journal of Chinese People’s Health
关键词
安可来
哮喘
Accolate
Asthma
